164 related articles for article (PubMed ID: 20870780)
1. Prevalence and independent factors for gastroduodenal ulcers/erosions in asymptomatic patients taking low-dose aspirin and gastroprotective agents: the OITA-GF study.
Tamura A; Murakami K; Kadota J;
QJM; 2011 Feb; 104(2):133-9. PubMed ID: 20870780
[TBL] [Abstract][Full Text] [Related]
2. Summaries for patients. Benefits and risks of continuing aspirin in patients with peptic ulcer bleeding.
Ann Intern Med; 2010 Jan; 152(1):I-20. PubMed ID: 19949137
[No Abstract] [Full Text] [Related]
3. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.
Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK
Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136
[TBL] [Abstract][Full Text] [Related]
4. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.
Uemura N; Sugano K; Hiraishi H; Shimada K; Goto S; Uchiyama S; Okada Y; Origasa H; Ikeda Y;
J Gastroenterol; 2014 May; 49(5):814-24. PubMed ID: 23754512
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease.
Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S234-6. PubMed ID: 19120904
[TBL] [Abstract][Full Text] [Related]
6. Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy.
Hokimoto S; Matsui K; Oshima S; Noda K; Kaikita K; Sumida H; Sugiyama S; Ogawa H
J Cardiol; 2009 Aug; 54(1):71-5. PubMed ID: 19632523
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of gastroduodenal ulcers/erosions in patients taking low-dose aspirin with either 15 mg/day of lansoprazole or 40 mg/day of famotidine: the OITA-GF study 2.
Tamura A; Murakami K; Kadota J;
BMC Res Notes; 2013 Mar; 6():116. PubMed ID: 23531145
[TBL] [Abstract][Full Text] [Related]
8. Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications.
Targownik LE; Metge CJ; Leung S
Aliment Pharmacol Ther; 2008 Jul; 28(1):88-96. PubMed ID: 18410563
[TBL] [Abstract][Full Text] [Related]
9. Incidence of and risk factors for upper gastrointestinal complications in patients taking low-dose aspirin in Japan.
Fujisawa N; Inamori M; Endo H; Uchiyama T; Hosono K; Akiyama T; Tomimoto A; Koyama S; Sawabe A; Tanida E; Yanagisawa S; Hata Y; Okada K; Atsukawa K; Watanabe S; Kawamura H; Higurashi T; Nagase H; Akimoto K; Matsuhashi N; Nakajima A
Hepatogastroenterology; 2011; 58(105):229-34. PubMed ID: 21510320
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use.
Iijima K; Shimosegawa T
Curr Pharm Des; 2015; 21(35):5056-65. PubMed ID: 26369687
[TBL] [Abstract][Full Text] [Related]
11. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
12. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
[TBL] [Abstract][Full Text] [Related]
13. [Role of proton pump inhibitor in the management of low dose aspirin related ulcerations].
Hiraishi H; Shimada T
Nihon Rinsho; 2010 Nov; 68(11):2096-101. PubMed ID: 21061539
[TBL] [Abstract][Full Text] [Related]
14. Low-dose aspirin-induced gastroduodenal mucosal injury in Japanese patients with arteriosclerotic disease.
Tamura I; Fujita T; Tsumura H; Morita Y; Yoshida M; Toyonaga T; Hirano S; Inokuchi H; Kutsumi H; Azuma T
Intern Med; 2010; 49(23):2537-45. PubMed ID: 21139290
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of gastroduodenal mucosal injuries in aspirin users.
Thongbai T
J Med Assoc Thai; 2013 Nov; 96(11):1423-7. PubMed ID: 24428091
[TBL] [Abstract][Full Text] [Related]
16. Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.
Nema H; Kato M
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S119-21. PubMed ID: 20586852
[TBL] [Abstract][Full Text] [Related]
17. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
[TBL] [Abstract][Full Text] [Related]
18. Teprenone for the prevention of low-dose aspirin-induced gastric mucosal injury in
Chitapanarux T; Lertprasertsuke N; Kongnak A
Scand J Gastroenterol; 2019 Oct; 54(10):1199-1204. PubMed ID: 31591940
[No Abstract] [Full Text] [Related]
19. [Prevention of gastroduodenal complications in patients taking low-dose aspirin].
Chryssostalis A; Marck G; Sibilia J; Chaussade S
Gastroenterol Clin Biol; 2004 Apr; 28 Spec No 3():C84-9. PubMed ID: 15366679
[TBL] [Abstract][Full Text] [Related]
20. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]